Herbalife (HLF) is back in focus after partnering with Cristiano Ronaldo on its "Fuel Like Ronaldo" wellness campaign and backing a new plant cell fermentation research center with IIT Madras, giving investors fresh catalysts to assess.
See our latest analysis for Herbalife.
Herbalife’s recent Ronaldo partnership and IIT Madras research tie up arrive as momentum appears mixed. The stock’s 1 week share price return of 7.3% contrasts with a 90 day share price decline of 15.5%, a 1 year total shareholder return of 51.3%, and a 5 year total shareholder loss of 76.4%.
If this kind of wellness themed story has you thinking more broadly about where growth and risk might show up next, it could be worth scanning 20 top founder-led companies as a starting point.
With Herbalife trading at $12.47, sitting at an 83% discount to one intrinsic value estimate and around 47% below analyst price targets, investors now have to ask: is this a genuine opportunity or is future growth already priced in?
Most Popular Narrative: 32% Undervalued
The most followed narrative on Herbalife suggests a fair value of about $18.33 against the recent $12.47 share price. This frames the current level as a sizeable discount that hinges on execution and future earnings quality.
The analysts have a consensus price target of $18.33 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.
Want to see what sits behind that spread between bullish and bearish views? The narrative focuses on measured revenue growth, firmer margins, and a future earnings multiple that all need to align before that fair value makes sense.
Result: Fair Value of $18.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Herbalife’s multi level marketing structure and rising regulatory scrutiny around supplement claims could still disrupt volumes and margins if oversight tightens or sentiment weakens.
Find out about the key risks to this Herbalife narrative.
Next Steps
With Herbalife pulled between concerns and optimism, it can be useful to move quickly and look through the data yourself to see what stands out. To weigh up both sides clearly, start by reviewing the 3 key rewards and 3 important warning signs
Looking for more investment ideas beyond Herbalife?
If you stop with Herbalife, you might miss other opportunities that better match your risk, income, or quality priorities, so widen your lens before making your next move.
- Spot potential bargains early by scanning 44 high quality undervalued stocks that pair compressed valuations with stronger fundamentals than the broader market.
- Strengthen your portfolio core with solid balance sheet and fundamentals stocks screener (48 results) that prioritize resilient finances over headline momentum.
- Get ahead of the crowd by tracking screener containing 18 high quality undiscovered gems that combine quality metrics with relatively low investor attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com